Animal models of peritoneal dialysis: Relevance, difficulties, and future;Modelos animales de diálisis peritoneal: Relevancia, dificultades y futuro

Nefrologia

Volumn 28, Issue SUPPL. 6, 2008, Pages 17-22

  Gonzalez Mateo G T ^a   Loureiro Alvarez J ^b   Rayego Mateos, S ^c   Ruiz Ortega, M ^c   Lopez Cabrera M ^a   Selgas, R ^a   Aroeira, Luiz Stark ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Peritoneal dialysis; Peritoneal dialysis experimental models; Peritoneal membrana; Ultrafiltration

Indexed keywords

ANIMAL; ANIMAL MODEL; CONFERENCE PAPER; FORECASTING; HUMAN; MOUSE; PERITONEAL DIALYSIS;

ANIMALS; FORECASTING; HUMANS; MICE; MODELS, ANIMAL; PERITONEAL DIALYSIS;

EID: 56049098216     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Di Paolo N, Sacchi G. Atlas of peritoneal histology. Perit Dial Int 2000; 20 (Supl. 3): S5-96.
2. Mateijsen MA, Van der Wal AC, Hendriks PM, Zweers MM, Mulder J, Struijk DG y cols. Vascular and interstitial changes in the peritoneum of capd patients with peritoneal sclerosis. Perit Dial Int 1999; 19: 517-25.
3. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR y cols. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-9.
4. Inagi R, Miyata T, Yamamoto T, Suzuki D, Urakami K, Saito A y cols. Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis. FEBS Lett 1999; 463: 260-4.
5. Margetts PJ, Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int 2003; 23: 530-41.
6. Zareie M, Hekking LH, Welten AG, Driesprong BA, Schadee-Eestermans IL, Faict D y cols. Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo. Nephrol Dial Transplant 2003; 18: 2629-37.
7. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C y cols. The euro-balance trial: The effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 2004; 66: 408-18.
8. Selgas R, Paiva A, Bajo MA, Cirugeda A, Aguilera A, Díaz C y cols. Consequences of peritonitis episodes appearing late during peritoneal dialysis (pd) in patients able to continue pd. Adv Perit Dial 1998; 14: 168-72.
9. Betjes MG, Visser CE, Zemel D, Tuk CW, Struijk DG, Krediet RT y cols. Intraperitoneal interleukin-8 and neutrophil influx in the initial phase of a capd peritonitis. Perit Dial Int 1996; 16: 385-92.
10. McLoughlin R. Resolving peritoneal inflammation: flicking the right «Switches». Perit Dial Int 2005; 25: 223-9.
11. Honda K, Nitta K, Horita S, Tsukada M, Itabashi M, Nihei H y cols. Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2003; 19: 169-75.
12. Jiménez-Heffernan JA, Cirugeda A, Bajo MA, Del Peso G, Pérez-Lozano ML, Perna C y cols. Tissue models of peritoneal fibrosis. Int J Artif Organs 2005; 28: 105-11.
13. Krediet RT, Zweers MM, Van der Wal AC, Struijk DG. Neoangiogenesis in the peritoneal membrane. Perit Dial Int 2000; 20 (Supl. 2): S19-25.
14. Aroeira LS, Aguilera A, Selgas R, Ramírez-Huesca M, Pérez-Lozano ML, Cirugeda A y cols. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J Kidney Dis 2005; 46: 938-48.
15. Pecoits-Filho R, Araujo MR, Lindholm B, Stenvinkel P, Abensur H, Romao JE Jr y cols. Plasma and dialysate il-6 and vegf concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 2002; 17: 1480-6.
16. Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramírez-Huesca M, Domínguez-Jiménez C, Jiménez-Heffernan JA y cols. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348: 403-13.
17. Jiménez-Heffernan JA, Aguilera A, Aroeira LS, Lara-Pezzi E, Bajo MA, Del Peso G y cols. Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis. Virchows Arch 2004; 444: 247-56.
18. Wieczorowska K, Khanna R, Moore HL, Nolph KD, Twardowski ZJ. Rat model of peritoneal fibrosis: preliminary observations. Adv Perit Dial 1995; 11: 48-51.
19. Bazargani F. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms. Swed Dent J Suppl 2005: 1-57, i.
20. Hurst SM, McLoughlin RM, Monslow J, Owens S, Morgan L, Fuller GM y cols. Secretion of oncostatin m by infiltrating neutrophils: regulation of il-6 and chemokine expression in human mesothelial cells. J Immunol 2002; 169: 5244-51.
21. Kim YL, Do J, Park SH, Cho K, Park J, Yoon K y cols. Low glucose degradation products dialysis solution modulates the levels of surrogate markers of peritoneal inflammation, integrity, and angiogenesis: preliminary report. Nephrology (Carlton) 2003; 8 Supl.: S28-32.
22. Gillerot G, Devuyst O. Molecular mechanisms modifying the peritoneal membrane exposed to peritoneal dialysis. Clin Nephrol 2003; 60: 1-6.
23. Lameire N, Van Biesen W, Mortier S, De Vriese A. What did we learn from animal models in peritoneal dialysis? Contrib Nephrol 2006; 150: 70-6.
24. Margetts PJ, Kolb M, Yu L, Hoff CM, Holmes CJ, Anthony DC y cols. Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum. Am J Pathol 2002; 160: 2285-94.
25. Margetts PJ, Bonniaud P, Liu L, Hoff CM, Holmes CJ, West-Mays JA y cols. Transient overexpression of tgf-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 2005; 16: 425-36.
26. Margetts PJ, Kolb M, Galt T, Hoff CM, Shockley TR, Gauldie J. Gene transfer of transforming growth factor-beta1 to the rat peritoneum: Effects on membrane function. J Am Soc Nephrol 2001; 12: 2029-39.
27. Mortier S, Lameire NH, De Vriese AS. Animal models in peritoneal dialysis research: a need for consensus. Perit Dial Int 2005; 25: 16-24.
28. Schwenger V, Morath C, Salava A, Amann K, Seregin Y, Deppisch R y cols. Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products. J Am Soc Nephrol 2006; 17: 199-207.
29. Ni J, Verbavatz JM, Rippe A, Boisde I, Moulin P, Rippe B y cols. Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis. Kidney Int 2006; 69: 1518-25.
30. Ni J, Cnops Y, Debaix H, Boisde I, Verbavatz JM, Devuyst O. Functional and molecular characterization of a peritoneal dialysis model in the c57bl/6j mouse. Kidney Int 2005; 67: 2021-31.
31. Shin SK, Kamerath CD, Gilson JF, Leypoldt JK. Effects of anaesthesia on fluid and solute transport in a c57bl6 mouse model of peritoneal dialysis. Nephrol Dial Transplant 2006; 21: 2874-80.